- Ongoing, recruitingHuman Pharmacology (Phase I)- Other
(22081) Open-label, fixed sequence crossover study to determine the effects of a single dose of elinzanetant (BAY 3427080) on the pharmacokinetics of dabigatran etexilate in healthy participants
This study is looking at how a new drug, BAY 3427080, affects levels of an existing blood-thinning medicine called dabigatran (Pradaxa) in healthy people. Researchers want to see if taking them together changes how much dabigatran is in the body.
For: Healthy volunteers (Vasomotor Symptoms as a sex hormone-dependent disorder in women and men)Germany - Ongoing, recruitingHuman Pharmacology (Phase I)- Other
(22424) Exploratory, randomized, non-blinded, crossover study to investigate the relative bioavailability of different elinzanetant soft gel capsules in healthy participants
This study is testing different versions of a new medicine called elinzanetant. It's looking at how much medicine gets into the body and how quickly, to find the best way to give it. Healthy men and women are taking part.
For: Vasomotor symptoms as a sex hormone-dependent disorder in women and menGermany - Ongoing, recruitingTherapeutic exploratory (Phase II)
(22423 NIRVANA) A randomized, parallel-group treatment, Phase 2, double-blind pilot study to investigate the efficacy and safety of elinzanetant compared with placebo for treatment of sleep disturbances associated with menopause
This study is testing a new medicine, elinzanetant, for women experiencing sleep problems during menopause. Researchers want to see if it helps improve sleep and if it's safe compared to a dummy pill.
For: Sleep disturbances associated with menopauseGermany · Austria · Belgium